rs7545236
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000130.5(F5):c.374-66T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,416,802 control chromosomes in the GnomAD database, including 42,645 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.33 ( 10859 hom., cov: 32)
Exomes 𝑓: 0.20 ( 31786 hom. )
Consequence
F5
NM_000130.5 intron
NM_000130.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.31
Publications
10 publications found
Genes affected
F5 (HGNC:3542): (coagulation factor V) This gene encodes an essential cofactor of the blood coagulation cascade. This factor circulates in plasma, and is converted to the active form by the release of the activation peptide by thrombin during coagulation. This generates a heavy chain and a light chain which are held together by calcium ions. The activated protein is a cofactor that participates with activated coagulation factor X to activate prothrombin to thrombin. Defects in this gene result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia, which is known as activated protein C resistance. [provided by RefSeq, Oct 2008]
F5 Gene-Disease associations (from GenCC):
- thrombophilia due to activated protein C resistanceInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- congenital factor V deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
- East Texas bleeding disorderInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 1-169560832-A-C is Benign according to our data. Variant chr1-169560832-A-C is described in ClinVar as Benign. ClinVar VariationId is 1286244.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.633 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F5 | ENST00000367797.9 | c.374-66T>G | intron_variant | Intron 3 of 24 | 1 | NM_000130.5 | ENSP00000356771.3 | |||
| F5 | ENST00000367796.3 | c.374-66T>G | intron_variant | Intron 3 of 24 | 5 | ENSP00000356770.3 |
Frequencies
GnomAD3 genomes AF: 0.326 AC: 49561AN: 151802Hom.: 10837 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
49561
AN:
151802
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.197 AC: 248991AN: 1264882Hom.: 31786 AF XY: 0.195 AC XY: 124318AN XY: 638590 show subpopulations
GnomAD4 exome
AF:
AC:
248991
AN:
1264882
Hom.:
AF XY:
AC XY:
124318
AN XY:
638590
show subpopulations
African (AFR)
AF:
AC:
16978
AN:
28462
American (AMR)
AF:
AC:
11970
AN:
43708
Ashkenazi Jewish (ASJ)
AF:
AC:
5140
AN:
24772
East Asian (EAS)
AF:
AC:
22886
AN:
38398
South Asian (SAS)
AF:
AC:
14097
AN:
81782
European-Finnish (FIN)
AF:
AC:
13485
AN:
52610
Middle Eastern (MID)
AF:
AC:
799
AN:
3726
European-Non Finnish (NFE)
AF:
AC:
150822
AN:
937930
Other (OTH)
AF:
AC:
12814
AN:
53494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
9943
19887
29830
39774
49717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5166
10332
15498
20664
25830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.327 AC: 49632AN: 151920Hom.: 10859 Cov.: 32 AF XY: 0.328 AC XY: 24397AN XY: 74280 show subpopulations
GnomAD4 genome
AF:
AC:
49632
AN:
151920
Hom.:
Cov.:
32
AF XY:
AC XY:
24397
AN XY:
74280
show subpopulations
African (AFR)
AF:
AC:
24696
AN:
41398
American (AMR)
AF:
AC:
4478
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
711
AN:
3470
East Asian (EAS)
AF:
AC:
3331
AN:
5112
South Asian (SAS)
AF:
AC:
932
AN:
4818
European-Finnish (FIN)
AF:
AC:
2706
AN:
10584
Middle Eastern (MID)
AF:
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12001
AN:
67956
Other (OTH)
AF:
AC:
648
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1430
2860
4291
5721
7151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1568
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.